Aquestive Therapeutics Inc. (AQST) Misses Q4 EPS by 13c

Aquestive Therapeutics Inc. (NASDAQ: AQST) reported Q4 EPS of ($0.26), $0.13 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $13 million versus the consensus estimate of $13.34 million.

For earnings history and earnings-related data on Aquestive Therapeutics Inc. (AQST) click here.

You May Also Be Interested In

• John Wiley & Sons, Inc. (WLY) Tops Q1 EPS by 4c ; Offers Guidance
• Silver Elephant announces $840,000 private placement at $0.12 per unit
• Hyperscale Data reports $0.95 net book value per share at June 30